Preventive anti-clotting therapy does not boost survival of critically ill COVID patients

February 03, 2021

BOSTON - Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.

"In patients critically ill with COVID-19, therapeutic dose anticoagulation started early in the ICU stay was not associated with improved survival,"says Hanny Al-Samkari, MD, an investigator in the Division of Hematology/Oncology at Massachusetts General Hospital (MGH) and lead author of a study reporting the findings in the journal (Whereas such patients almost always receive low, "prophylactic-dose" anticoagulation, therapeutic doses are much higher.)

Al-Samkari and colleagues at MGH, Brigham and Women's Hospital, and Harvard Medical School (HMS) analyzed health records from STOP-COVID (Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19), a multicenter study that included adults 18 and older who had laboratory-confirmed COVID-19 and were admitted to participating ICUs at 67 geographically diverse hospitals in the United States.

The researchers evaluated the incidence of venous thromboembolism (VTE), a serious and potentially fatal blood clotting event, as well as the occurrence of major, life-threatening bleeding. They also examined the effects of early therapeutic anticoagulation on survival.

To do this, they used data from the study to simulate a randomized clinical trial in which patients are randomly assigned to receive or not receive therapeutic anticoagulation within two days of being admitted to an ICU. The model took into account detailed data on demographics, comorbidities, medications and severity of illness that might otherwise influence the results.

They found that 6.3% of the 3,239 patients had VTE confirmed on imaging studies and 2.8% had major bleeding events. The incidence of VTE was considerably less frequent than in previous, mostly smaller studies of patients with COVID-19, which reported VTE rates as high as 42%.

The only factors that accurately predicted higher risk for VTE were male sex and higher circulating levels of D-dimer, a protein fragment produced when a blood clot breaks up.

Importantly, the results showed that there was no survival benefit for patients who received therapeutic anticoagulation in the first two days of an ICU stay compared with patients who did not receive early therapeutic anticoagulation.

"We looked at multiple subgroups of patients, including by age, sex and severity of illness, and we did not find any subgroup that benefited from early therapeutic anticoagulation," says senior author and principal investigator of STOP-COVID, David E. Leaf, MD, MMSc, director of clinical and translational research in acute kidney injury in the

The study results also reinforce that "bleeding matters. Bleeding is not trivial in these patients," Al-Samkari says. Of the 90 patients who had a major bleeding event in the study, 60 were receiving therapeutic anticoagulation at the time of the event, and 56 of the 90 patients (62%) with a major bleed died within 28 days. The most common sites of bleeding were in the gastrointestinal tract and within the skull.

In addition to the clinical findings, the study results support the use of target trial emulation, the type of simulation the researchers used, to quickly acquire information that can be used to improve clinical care in a rapidly changing environment, says co-first author Shruti Gupta, MD, MPH, from the Division of Renal Medicine at the Brigham.

"This is another example of how target trial emulation, which we've used in other important studies from our STOP-COVID consortium, can be applied to observational data and allow us to estimate the effects of different treatments on clinical outcomes. This is particularly important because randomized clinical trials often take time and require large numbers of patients to see meaningful differences in outcomes," she says.

Clinical staff at member institutions of the STOP-COVID consortium contributed data to the study. There was no outside funding source.
About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The

About Brigham and Women's Hospital

Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, the Brigham and Women's Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health's 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham's medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women's Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit

Massachusetts General Hospital

Related Intensive Care Unit Articles from Brightsurf:

Hospital COVID-19 risk lowest among intensive care staff
Contrary to expectations, the risk of COVID-19 infection among hospital staff at the height of the coronavirus pandemic was lowest among intensive care clinicians, reveals a study of one major UK medical centre, published in the journal Thorax.

Pregnant women with COVID-19 may more likely need intensive care and give birth early
Pregnant women seen in hospitals with covid-19 are less likely to show symptoms, and seem to be at increased risk of needing admission to an intensive care unit than non-pregnant women of similar age, finds a study published by The BMJ today.

Many children in intensive care may not be getting rehabilitation therapy, study shows
Adult patients in hospital intensive care units (ICUs) are often given rehabilitation therapy and urged to keep mobile from an early point in their hospital stays.

Demand for US hospital inpatient, intensive care unit beds for patients with COVID-19
The intensive care unit and inpatient bed needs for patients with coronavirus disease 2019 (COVID-19) in two cities in China are described and compared to estimate the peak number of intensive care unit beds needed in US cities if an outbreak equivalent to that in Wuhan occurs.

Cognitive impairment after intensive care linked to long-lasting inflammation
People who have been treated in intensive care commonly suffer from residual cognitive impairment, but the reason for this is unknown.

New guidelines for hepatic failure in the intensive care unit
For critical care specialists, hepatic failure poses complex challenges unlike those of other critical illnesses.

Hospital critical care resuscitation unit improves patients' chances of survival
Patients with acutely life-threatening health conditions who were treated in the innovative Critical Care Resuscitation Unit (CCRU) received faster treatment and had better health outcomes, including a 36 percent lower risk of dying than those who were transferred from a hospital's emergency department then evaluated and treated in a traditional intensive care unit, according to a recent study in the Journal of Emergency Medicine conducted by researchers at the University of Maryland School of Medicine.

Once scarce, neonatal intensive care proliferates
Is NICU care being driven by medical need or competition?

Emergency medicine: Department-based intensive care unit improves patient survival rates
A new Michigan Medicine study found that implementing a dedicated emergency medicine department-based intensive care unit improved patient survival rates and lowered inpatient intensive care unit (ICU) admissions.

Shorter rotations in intensive care units mitigate burnout among physicians
Shortening the length of rotations in a medical intensive care unit (MICU) from the traditional 14-consecutive day schedule to only seven days helps mitigate burnout among critical care physicians, according to a new Penn Medicine pilot study.

Read More: Intensive Care Unit News and Intensive Care Unit Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to